HCPCS Codes for Medical care


  • J7684

    Triamcinolone, inhalation solution, compounded product, administered through dme, unit dose form, per milligram
  • J7685

    Tobramycin, inhalation solution, compounded product, administered through dme, unit dose form, per 300 milligrams
  • J7686

    Treprostinil, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, 1.74 mg
  • J7699

    Noc drugs, inhalation solution administered through dme
  • J7799

    Noc drugs, other than inhalation drugs, administered through dme
  • J7999

    Compounded drug, not otherwise classified
  • J8498

    Antiemetic drug, rectal/suppository, not otherwise specified
  • J8499

    Prescription drug, oral, non chemotherapeutic, nos
  • J8501

    Aprepitant, oral, 5 mg
  • J8502

    Injection, aprepitant (aponvie), 1 mg
  • J8510

    Busulfan; oral, 2 mg
  • J8515

    Cabergoline, oral, 0.25 mg
  • J8520

    Capecitabine, oral, 150 mg
  • J8521

    Capecitabine, oral, 500 mg
  • J8522

    Capecitabine, oral, 50 mg
  • J8530

    Cyclophosphamide; oral, 25 mg
  • J8540

    Dexamethasone, oral, 0.25 mg
  • J8541

    Dexamethasone (hemady), oral, 0.25 mg
  • J8560

    Etoposide; oral, 50 mg
  • J8597

    Antiemetic drug, oral, not otherwise specified
  • J8600

    Melphalan; oral, 2 mg
  • J8610

    Methotrexate; oral, 2.5 mg
  • J8611

    Methotrexate (jylamvo), oral, 2.5 mg
  • J8612

    Methotrexate (xatmep), oral, 2.5 mg
  • J8650

    Nabilone, oral, 1 mg
  • J8655

    Netupitant 300 mg and palonosetron 0.5 mg, oral
  • J8670

    Rolapitant, oral, 1 mg
  • J8700

    Temozolomide, oral, 5 mg
  • J8705

    Topotecan, oral, 0.25 mg
  • J8999

    Prescription drug, oral, chemotherapeutic, nos
  • J9000

    Injection, doxorubicin hydrochloride, 10 mg
  • J9003

    Leuprolide injectable (camcevi etm), 1 mg
  • J9010

    Injection, alemtuzumab, 10 mg
  • J9011

    Injection, datopotamab deruxtecan-dlnk, 1 mg
  • J9015

    Injection, aldesleukin, per single use vial
  • J9017

    Injection, arsenic trioxide, 1 mg
  • J9019

    Injection, asparaginase (erwinaze), 1,000 iu
  • J9020

    Injection, asparaginase, not otherwise specified, 10,000 units
  • J9021

    Injection, asparaginase, recombinant, (rylaze), 0.1 mg
  • J9022

    Injection, atezolizumab, 10 mg
  • J9023

    Injection, avelumab, 10 mg
  • J9024

    Injection, atezolizumab, 5 mg and hyaluronidase-tqjs
  • J9025

    Injection, azacitidine, 1 mg
  • J9026

    Injection, tarlatamab-dlle, 1 mg
  • J9027

    Injection, clofarabine, 1 mg
  • J9028

    Injection, nogapendekin alfa inbakicept-pmln, for intravesical use, 1 microgram
  • J9029

    Intravesical instillation, nadofaragene firadenovec-vncg, per therapeutic dose
  • J9030

    Bcg live intravesical instillation, 1 mg
  • J9031

    Bcg (intravesical) per instillation
  • J9032

    Injection, belinostat, 10 mg